As of May 29
| -0.10 / -2.74%|
The 6 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 6.25, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +76.06% increase from the last price of 3.55.
The current consensus among 6 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.